J.P. Morgan Day 4: Setting Goals For The Year Ahead
Updates from Viatris, Chi-Med, Novo Nordisk, Sangamo, Intercept, ImmunoGen
Daily round-up from the virtual J.P. Morgan Healthcare Conference: Viatris debuts; Chi-Med charts its own path; Novo takes another go at obesity; Sangamo moves forward with CAR-Treg; Intercept readies for resubmission; and ImmunoGen is relying on a safety advantage for its ADC.
